323990.KQ
Vaxcell-Bio Therapeutics Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 4,490.00
−10.56%Margins
Gross margin
-18.8%
EBITDA margin
-207.8%
EBIT margin
-258.3%
Net margin
-229.1%
FCF margin
-275.5%
-28.0%
Return on equity
-25.4%
Return on assets
-30.7%
Return on invested capital
0.11x
Asset turnover
-KRW 10.6B
Cash from operations
KRW 638
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026